• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索阿片类物质使用障碍治疗药物的生活体验:一项众包便利样本的定性研究

Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.

作者信息

Victor Grant, Kheibari A, Strickland J C

机构信息

School of Social Work, Rutgers University, 120 Albany St, New Brunswick, NJ, 08901, USA.

School of Social Work, Wayne State University, 5447 Woodward Ave, Detroit, MI, 48202, USA.

出版信息

Community Ment Health J. 2025 Apr;61(3):411-419. doi: 10.1007/s10597-024-01345-9. Epub 2024 Sep 5.

DOI:10.1007/s10597-024-01345-9
PMID:39235576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11868299/
Abstract

Given the effectiveness of medication for opioid use disorder (MOUD) and low engagement of treatment among people who use drugs (PWUD), it is important to better understand how to engage treatment clients with MOUD care. The current study aimed to achieve this goal by using qualitative methodology to characterize the MOUD treatment experiences. Participants (N = 52) were recruited for an online semi-structured interview. Qualitative analysis revealed varied treatment experiences, with the majority expressing irregular and intermittent MOUD treatment engagement. The therapeutic effects of MOUD in curbing withdrawal symptoms in conjunction with counseling services was frequently mentioned, as well as a preference for methadone maintenance treatment (MMT) to buprenorphine or naltrexone. Many participants described barriers to treatment and continuation of care, including failed drug screens for non-opioid drugs, perceived stigma, and physician-initiated discontinuation of treatment. The current study revealed that patients had favorable experiences with MOUD treatment, particularly when supplemented with counseling services.

摘要

鉴于药物治疗阿片类物质使用障碍(MOUD)的有效性以及吸毒者(PWUD)对治疗的低参与度,更好地了解如何让治疗客户接受MOUD护理非常重要。当前的研究旨在通过使用定性方法来描述MOUD治疗经历来实现这一目标。招募了参与者(N = 52)进行在线半结构化访谈。定性分析揭示了不同的治疗经历,大多数人表示MOUD治疗参与不规律且断断续续。经常提到MOUD在结合咨询服务抑制戒断症状方面的治疗效果,以及对美沙酮维持治疗(MMT)优于丁丙诺啡或纳曲酮的偏好。许多参与者描述了治疗和持续护理的障碍,包括非阿片类药物药物筛查失败、感知到的耻辱感以及医生发起的治疗中断。当前的研究表明,患者对MOUD治疗有良好的体验,特别是在辅以咨询服务时。

相似文献

1
Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.探索阿片类物质使用障碍治疗药物的生活体验:一项众包便利样本的定性研究
Community Ment Health J. 2025 Apr;61(3):411-419. doi: 10.1007/s10597-024-01345-9. Epub 2024 Sep 5.
2
Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults.美国成年人多样化样本中阿片类药物使用障碍药物的认知情况。
J Subst Use Addict Treat. 2024 Aug;163:209361. doi: 10.1016/j.josat.2024.209361. Epub 2024 May 3.
3
College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.两所美国大学的大学生对阿片类药物使用障碍治疗方法的认知和感知有用性。
Am J Drug Alcohol Abuse. 2020 Sep 2;46(5):589-603. doi: 10.1080/00952990.2020.1757686. Epub 2020 Jun 16.
4
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.出狱后对纳曲酮、美沙酮和丁丙诺啡延长释放治疗的看法。
Addict Sci Clin Pract. 2019 Oct 1;14(1):37. doi: 10.1186/s13722-019-0166-0.
5
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.扩大监狱中阿片类药物使用障碍(MOUD)药物的获取途径:一项综合项目评估。
J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9.
6
Pregnancy Rates Among Women Treated with Medication for Opioid Use Disorder.接受阿片类药物使用障碍药物治疗的女性的妊娠率。
J Gen Intern Med. 2024 Jun;39(8):1342-1348. doi: 10.1007/s11606-024-08689-8. Epub 2024 Feb 29.
7
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder.物质使用障碍咨询师对阿片类物质使用障碍药物治疗利弊的看法。
Addict Sci Clin Pract. 2025 Feb 4;20(1):7. doi: 10.1186/s13722-025-00537-2.
8
Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.评估关于阿片类药物使用障碍和纳洛酮药物在 Twitter 上的认知。
J Addict Dis. 2021 Jan-Mar;39(1):37-45. doi: 10.1080/10550887.2020.1811456. Epub 2020 Aug 24.
9
Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.家族对患有阿片类药物使用障碍的家庭成员的适当治疗类型和目标的看法。
Drug Alcohol Depend. 2021 Apr 1;221:108649. doi: 10.1016/j.drugalcdep.2021.108649. Epub 2021 Feb 22.
10
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type.用于阿片类物质使用障碍的药物:美国退伍军人中早期停药及按药物类型降低过量用药风险的预测因素
Addiction. 2025 Jan;120(1):138-151. doi: 10.1111/add.16659. Epub 2024 Sep 7.

本文引用的文献

1
Treatment for Opioid Use Disorder: Population Estimates - United States, 2022.阿片类药物使用障碍治疗:人群估计-美国,2022 年。
MMWR Morb Mortal Wkly Rep. 2024 Jun 27;73(25):567-574. doi: 10.15585/mmwr.mm7325a1.
2
Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs.COVID-19 大流行期间 10 个州医疗补助计划中治疗阿片类药物使用障碍药物的使用趋势。
JAMA Health Forum. 2023 Jun 2;4(6):e231422. doi: 10.1001/jamahealthforum.2023.1422.
3
State Policies Could Impede New Efforts to Increase Access to Medications for Opioid Use Disorder.国家政策可能会阻碍为增加阿片类药物使用障碍治疗药物可及性而做出的新努力。
JAMA Health Forum. 2023 Mar 3;4(3):e230071. doi: 10.1001/jamahealthforum.2023.0071.
4
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis.新冠疫情放松美沙酮居家服药规定后,两家农村阿片类药物治疗项目中的治疗保留率、重返使用率和康复支持:混合方法分析。
J Subst Abuse Treat. 2022 Oct;141:108801. doi: 10.1016/j.jsat.2022.108801. Epub 2022 May 8.
5
Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic.COVID-19 大流行第一年美沙酮类物质处方的变化。
JAMA Netw Open. 2022 Mar 1;5(3):e224058. doi: 10.1001/jamanetworkopen.2022.4058.
6
Peer recovery services for persons returning from prison: Pilot randomized clinical trial investigation of SUPPORT.同伴康复服务对刑满释放人员的影响:SUPPORT 的试点随机临床试验研究。
J Subst Abuse Treat. 2021 Jul;126:108339. doi: 10.1016/j.jsat.2021.108339. Epub 2021 Feb 27.
7
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.谁会留在药物治疗中来治疗阿片类药物使用障碍?一项针对门诊专科治疗环境的全国性研究。
J Subst Abuse Treat. 2021 Jul;126:108329. doi: 10.1016/j.jsat.2021.108329. Epub 2021 Feb 18.
8
Designing and implementing an intervention for returning citizens living with substance use disorder: discovering the benefits of peer recovery coach involvement in pilot clinical trial decision-making.为患有物质使用障碍的归国公民设计并实施一项干预措施:发现同伴康复教练参与试点临床试验决策的益处。
J Offender Rehabil. 2021;60(2):138-158. doi: 10.1080/10509674.2020.1863301. Epub 2021 Jan 11.
9
Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.评估心理社会干预辅助阿片类激动剂治疗药物使用障碍的比较效果:系统评价和网络荟萃分析。
PLoS One. 2020 Dec 28;15(12):e0244401. doi: 10.1371/journal.pone.0244401. eCollection 2020.
10
Designing an "Ideal" Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder.设计一个“理想”的物质使用障碍治疗中心:使用阿片类药物治疗药物使用障碍的人的观点。
Qual Health Res. 2021 Feb;31(3):512-522. doi: 10.1177/1049732320971231. Epub 2020 Nov 19.